Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman

Showing results (431-440 of 36,419) with videos related to

Pageof 3,642
Sort By:
British Journal of Anaesthesia|December 1, 1980
The intensity and duration of action of I.V. drugsJ Norman
Expert Opinion on Therapeutic Patents|May 15, 2015
Evaluation of US20150011555. An inhaled IP receptor agonist for the treatment of pulmonary arterial hypertensionPeter Norman
Medical Informatics = Medecine Et Informatique|June 10, 1998
Organizing medical networked information (OMNI)F Norman
Science (New York, N.Y.)|November 16, 1984
President vetoes NIH billC Norman
The Diabetes Educator|April 29, 1998
Education--a lifelong processJ Norman
Microorganisms|March 29, 2023
Correction: Latov, N. <i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy. <i>Microorganisms</i> 2022, <i>10</i>, 2139Norman Latov
Expert Opinion on Therapeutic Patents|September 14, 2012
Selective JAK1 inhibitor and selective Tyk2 inhibitor patentsPeter Norman
International Journal of Nursing Studies|May 20, 2014
Editorial debate on the future of nurse educationIan Norman
Expert Opinion on Therapeutic Patents|January 7, 2014
Evaluation of WO2013116562A, an orally active PI3Kδ inhibitor for the treatment of asthmaPeter Norman
Nature Reviews. Neurology|July 2, 2014
Diagnosis and treatment of chronic acquired demyelinating polyneuropathiesNorman Latov
Pageof 3,642

Showing results (431-440 of 36,419) with videos related to

Sort By:
Pageof 3,642
British Journal of Anaesthesia|December 1, 1980
The intensity and duration of action of I.V. drugsJ Norman
Expert Opinion on Therapeutic Patents|May 15, 2015
Evaluation of US20150011555. An inhaled IP receptor agonist for the treatment of pulmonary arterial hypertensionPeter Norman
Medical Informatics = Medecine Et Informatique|June 10, 1998
Organizing medical networked information (OMNI)F Norman
Science (New York, N.Y.)|November 16, 1984
President vetoes NIH billC Norman
The Diabetes Educator|April 29, 1998
Education--a lifelong processJ Norman
Microorganisms|March 29, 2023
Correction: Latov, N. <i>Campylobacter jejuni</i> Infection, Anti-Ganglioside Antibodies, and Neuropathy. <i>Microorganisms</i> 2022, <i>10</i>, 2139Norman Latov
Expert Opinion on Therapeutic Patents|September 14, 2012
Selective JAK1 inhibitor and selective Tyk2 inhibitor patentsPeter Norman
International Journal of Nursing Studies|May 20, 2014
Editorial debate on the future of nurse educationIan Norman
Expert Opinion on Therapeutic Patents|January 7, 2014
Evaluation of WO2013116562A, an orally active PI3Kδ inhibitor for the treatment of asthmaPeter Norman
Nature Reviews. Neurology|July 2, 2014
Diagnosis and treatment of chronic acquired demyelinating polyneuropathiesNorman Latov
Pageof 3,642